Late-day immunotherapy infusions may affect overall survival in patients with melanoma
- PMID: 35266675
- DOI: 10.1002/cncr.34153
Late-day immunotherapy infusions may affect overall survival in patients with melanoma
Comment on
-
Effect of immunotherapy time-of-day infusion on overall survival among patients with advanced melanoma in the USA (MEMOIR): a propensity score-matched analysis of a single-centre, longitudinal study.Lancet Oncol. 2021 Dec;22(12):1777-1786. doi: 10.1016/S1470-2045(21)00546-5. Epub 2021 Nov 12. Lancet Oncol. 2021. PMID: 34780711 Clinical Trial.
References
-
- Qian DC, Kleber T, Brammer B, et al. Effect of immunotherapy time-of-day infusion on overall survival among patients with advanced melanoma in the USA (MEMOIR): a propensity score-matched analysis of a single-centre, longitudinal study. Lancet Oncol. 2021;22:P1777-P1786. doi:10.1016/S1470-2045(21)00546-5
-
- Zhang H, Liu Y, Liu D, et al. Time of day influences immune response to an inactivated vaccine against SARS-CoV-2. Cell Res. 2021;31:1215-1217. doi:10.1038/s41422-021-00541-6
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical